|
⚲
|
| Keyboard |
| Allogene Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001737287 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001737287] | |
| 10-Q | [0001737287] | |
| 3 | [0001737287] | |
| 4 | [0001737287] | |
| 5 | [0001737287] | |
| 8-K | [0001737287] | |
| D | [0001737287] | |
| SC 13D | [0001737287] | |
| SC 13G | [0001737287] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Allogene Therapeutics Inc | |
| Roberts Zachary | |
| Humer Franz B | |
| Sato Vicki L | |
| Kazam Joshua A | |
| Barrett Elizabeth A | |
| Messemer Deborah M | |
| Mayo Stephen | |
| Witte Owen N | |
| Yoshiyama Annie | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Allogene Therapeutics Inc ALLO
Common Stock
|
2026-03-16 | Sell | 47,763 | $2.47 | 117,975 |
|
Allogene Therapeutics Inc ALLO
Common Stock
|
2026-03-16 | Sell | 4,835 | $2.47 | 11,942 |
|
Allogene Therapeutics Inc ALLO
Common Stock
|
2026-03-02 | Sell | 7,132 | $2.60 | 18,543 |
|
Allogene Therapeutics Inc ALLO
Stock Option (Right to buy) · derivative
|
2026-02-02 | Grant | 373,757 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Common Stock
|
2026-02-02 | Sell | 22,900 | $1.76 | 40,304 |
|
Allogene Therapeutics Inc ALLO
Stock Option (Right to buy) · derivative
|
2026-02-02 | Grant | 1,387,931 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Common Stock
|
2026-02-02 | Sell | 24,001 | $1.76 | 42,242 |
|
Allogene Therapeutics Inc ALLO
Stock Option (Right to buy) · derivative
|
2026-02-02 | Grant | 718,763 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Restricted Stock Unit · derivative
|
2026-02-02 | Grant | 203,307 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Common Stock
|
2026-02-02 | Sell | 4,167 | $1.72 | 7,167 |
|
Allogene Therapeutics Inc ALLO
Stock Option (Right to buy) · derivative
|
2026-02-02 | Grant | 179,691 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Restricted Stock Unit · derivative
|
2026-02-02 | Grant | 392,586 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Restricted Stock Unit · derivative
|
2026-02-02 | Grant | 263,033 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Common Stock
|
2026-02-02 | Sell | 35,700 | $1.77 | 63,189 |
|
Allogene Therapeutics Inc ALLO
Stock Option (Right to buy) · derivative
|
2026-02-02 | Grant | 539,072 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Stock Option (Right to buy) · derivative
|
2026-02-02 | Grant | 539,072 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Restricted Stock Unit · derivative
|
2026-02-02 | Grant | 50,827 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Common Stock
|
2026-02-02 | Sell | 7,549 | $1.73 | 13,060 |
|
Allogene Therapeutics Inc ALLO
Restricted Stock Unit · derivative
|
2026-02-02 | Grant | 152,480 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Stock Option (Right to buy) · derivative
|
2026-02-02 | Grant | 929,913 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||